The company is active in research related to the intestinal microbiome, particularly in genome sequencing and custom formulation of probiotics, as well as in the creation and marketing of software for genomic testing and the manufacture of customized probiotics. The company may, either on its own behalf or on behalf of third parties, carry out all operations of any kind, directly or indirectly related to its purpose, create branches or subsidiaries in Switzerland and abroad, participate in all enterprises in Switzerland or abroad having a direct or indirect connection with its purpose, and grant loans or guarantees to associates or third parties, if it serves its interests.